Delhivery Limited Incorporates Wholly Owned Subsidiary ‘Delhivery Fintech Distribution Private Limited’

Delhivery Limited has officially announced the incorporation of its wholly owned subsidiary, Delhivery Fintech Distribution Private Limited. The Ministry of Corporate Affairs approved the formation of this new entity on June 2, 2026. This strategic move follows the Board of Directors’ approval on May 16, 2026, aimed at expanding the company’s operational reach and service offerings within the fintech distribution space in India. The company has updated its website with this development.

Subsidiary Incorporation Confirmed

Delhivery Limited has taken a significant step in its expansion strategy with the official incorporation of a new wholly owned subsidiary. Named Delhivery Fintech Distribution Private Limited, the company received approval from the Ministry of Corporate Affairs on June 2, 2026. This development is a direct follow-up to the Board of Directors’ initial approval granted on May 16, 2026, underscoring the company’s commitment to growing its presence in the fintech sector.

Strategic Expansion

The establishment of Delhivery Fintech Distribution Private Limited signifies Delhivery’s intent to further diversify and strengthen its service portfolio, particularly in areas related to financial technology distribution. This move is expected to enhance the company’s capabilities and market reach within India’s rapidly evolving fintech landscape. Further details regarding the subsidiary’s operational focus will be made available as the company progresses.

Public Disclosure

In line with its commitment to transparency and regulatory compliance, Delhivery Limited has made this information publicly available. The company has also uploaded the disclosure on its official website, www.delhivery.com, ensuring that stakeholders have access to key updates regarding its corporate activities and strategic initiatives. This announcement follows previous disclosures made on May 16, 2026.

Source: BSE

Previous Article

Concord Biotech Secures USFDA Approval for Mycophenolate Mofetil Oral Suspension

Next Article

Patanjali Foods Limited Responds to Show Cause Notices Regarding Alleged Wrongful ITC Claims